A clinical trial is testing a new drug that may slow the progression of Parkinson’s disease (PD). Confirm your eligibility from home, with an at-home saliva sample.
Eligibility Criteria:
- Diagnosis of Parkinson’s disease
- Age 50–80
- Not currently on symptomatic therapy (i.e. not on any PD meds yet), and
not expected to require symptomatic therapy within the next 12 months
- No postural instability
